Keywords: pierre, fabre, teams, forest, cns, drug, french

Pierre Fabre teams with Forest for CNS drug

Article | 12 January 2009

Print This

French independent drugmaker Pierre Fabre and the USA's Forest Laboratories have signed an agreement to develop and the market F2695, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in